Preoperative plasma fibrinogen is associated with poor prognosis in esophageal carcinoma: a meta-analysis
The aim of this meta-analysis was to investigate preoperative plasma fibrinogen (PPF) as a prognostic marker in esophageal carcinoma (EC) by meta-analysis.
Relevant studies were sought in the databases including Pubmed, Web of Science, Cochrane library, and Wanfang databases up to Oct 10th, 2017. Hazard ratios (HRs) with corresponding 95% confidence intervals (CIs) were used as effective value, and pooled HRs were synthesized by STATA 14.0 to assess the prognostic impact of PPF on EC patients.
A total of 8 studies with 2827 patients were collected in this meta-analysis. Our results revealed that high PPF was significantly associated with poor OS (HR = 1.90, 95% CI 1.56–2.33, P = 0.000; HR = 1.76, 95% CI 1.28–2.42, P = 0.000) and poor DFS (HR = 1.91, 95% CI 1.50–2.43, P = 0.000; HR = 1.51, 95% CI 1.16–1.97, P = 0.000) in EC patients from univariate and multivariate analysis results, respectively, which suggested that EC patients with high PPF will suffer from high postoperative mortality and recurrence rate.
High PPF was significantly associated with poor OS and DFS in EC patients. Fibrinogen can serve as a prognostic marker and even a future targeting molecule during the treatment of EC patients.
KeywordsPreoperative plasma fibrinogen (PPF) Esophageal carcinoma (EC) Prognosis Meta-analysis
Compliance with ethical standards
Conflict of interests
All the authors declare there is no conflict of interest in this research.
This article does not contain any studies with human participants or animals performed by any of the authors.
- 18.Matsuda S, Takeuchi H, Fukuda K, Nakamura R, Takahashi T, Wada N, et al. Clinical significance of plasma fibrinogen level as a predictive marker for postoperative recurrence of esophageal squamous cell carcinoma in patients receiving neoadjuvant treatment. Dis Esophagus. 2014;27(7):654–61.CrossRefPubMedGoogle Scholar
- 21.Sun XD, Shi XJ, Chen YG, Wang CL, Ma Q, Lv GY. Elevated preoperative neutrophil–lymphocyte ratio is associated with poor prognosis in hepatocellular carcinoma patients treated with liver transplantation: a meta-analysis. Gastroenterol Res Pract. 2016;2016:4743808. https://doi.org/10.1155/2016/4743808 (Epub 2015 Dec 30).PubMedCrossRefGoogle Scholar
- 25.Zhang F, Wang Y, Sun P, Wang ZQ, Wang DS, Zhang DS, et al. Fibrinogen promotes malignant biological tumor behavior involving epithelial–mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2017;. https://doi.org/10.1007/s00432-017-2493-4.CrossRefPubMedPubMedCentralGoogle Scholar
- 28.Qiao CR, Zhao S, Li XN, Zhao J, Zhu DY, Wu K, et al. The prognostic and clinicopahtological role of peripheral plasma fibrinogen and platelete in esophageal squamous cell carcinoma. Chin J of Gerontol. 2016;1(36):348–50 (Article in Chinese).Google Scholar
- 30.Arigami T, Okumura H, Matsumoto M, Uchikado Y, Uenosono Y, Kita Y, et al. Analysis of the fibrinogen and neutrophil-lymphocyte ratio in esophageal squamous cell carcinoma: a promising blood marker of tumor progression and prognosis. Medicine (Baltimore). 2015;94(42):e1702.CrossRefPubMedPubMedCentralGoogle Scholar